Central Success Developments Limited - Net Worth and Insider Trading
Central Success Developments Limited Net Worth
The estimated net worth of Central Success Developments Limited is at least $1.3 Billion dollars as of 2024-09-25. Central Success Developments Limited is the 2101 Beneficial owner of Consun Pharmaceutical Group Ltd and owns about 197,324,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) stock worth over $1.3 Billion. Details can be seen in Central Success Developments Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Central Success Developments Limited has not made any transactions after 2022-01-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Central Success Developments Limited
Central Success Developments Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Central Success Developments Limited owns 1 companies in total, including Consun Pharmaceutical Group Ltd (HKSE:01681) .
Insider Ownership Summary of Central Success Developments Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01681 | Consun Pharmaceutical Group Ltd | 2022-01-26 | 2101 Beneficial owner |
Central Success Developments Limited Latest Holdings Summary
Central Success Developments Limited currently owns a total of 1 stock. Central Success Developments Limited owns 197,324,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) as of January 26, 2022, with a value of $1.3 Billion.
Latest Holdings of Central Success Developments Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01681 | Consun Pharmaceutical Group Ltd | 2022-01-26 | 197,324,000 | 6.54 | 1,290,498,960 |
Holding Weightings of Central Success Developments Limited
Central Success Developments Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Central Success Developments Limited has made a total of 1 transactions in Consun Pharmaceutical Group Ltd (HKSE:01681) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Consun Pharmaceutical Group Ltd is the sale of 0 shares on January 26, 2022, which brought Central Success Developments Limited around $0.
Insider Trading History of Central Success Developments Limited
- 1
Central Success Developments Limited Trading Performance
GuruFocus tracks the stock performance after each of Central Success Developments Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Central Success Developments Limited is -11.49%. GuruFocus also compares Central Success Developments Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Central Success Developments Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Central Success Developments Limited's insider trading performs compared to the benchmark.
Performance of Central Success Developments Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.21 | | | | | |
| Relative Return to S&P 500(%) | -13.98 | | | | | |
Central Success Developments Limited Ownership Network
Central Success Developments Limited Owned Company Details
What does Consun Pharmaceutical Group Ltd do?
Who are the key executives at Consun Pharmaceutical Group Ltd?
Central Success Developments Limited is the 2101 Beneficial owner of Consun Pharmaceutical Group Ltd. Other key executives at Consun Pharmaceutical Group Ltd include 2101 Beneficial owner Double Grace International Limited , 2101 Beneficial owner Li Qian , and 2101 Beneficial owner An Yubao .
Consun Pharmaceutical Group Ltd (HKSE:01681) Insider Trades Summary
Over the past 18 months, Central Success Developments Limited made no insider transaction in Consun Pharmaceutical Group Ltd (HKSE:01681). Other recent insider transactions involving Consun Pharmaceutical Group Ltd (HKSE:01681) include a net sale of 9,219,000 shares made by Li Qian , a net sale of 9,219,000 shares made by An Yubao , and a net sale of 0 shares made by Double Grace International Limited .
In summary, during the past 3 months, insiders sold 0 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,438,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,438,000 shares.
Consun Pharmaceutical Group Ltd (HKSE:01681)'s detailed insider trading history can be found in Insider Trading Tracker table.
Consun Pharmaceutical Group Ltd Insider Transactions
Central Success Developments Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Central Success Developments Limited. Currently GuruFocus does not have mailing address information for Central Success Developments Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
